What is Rein Therapeutics Inc (RNTX) stock price today?

Rein Therapeutics Inc (RNTX) currently trades at $1.36 per share. The stock has a market capitalization of $40.66M and a P/E ratio of —x.

Is RNTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Rein Therapeutics Inc has a Smart Value Score of 19/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

RNTX

Rein Therapeutics Inc

NASDAQ: RNTX · HEALTHCARE · BIOTECHNOLOGY

$1.36

+6.27% today

Updated 2026-04-30

Market cap

$40.66M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.96

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

Market cap

$40.66M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.96

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$10.00

+638.01%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.22M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-27329.00	$-15732.00	$-62.88M	$-49.87M	$-31.97M
EPS	—	—	—	—	$-1.96
Free cash flow	$-24.86M	$-19.81M	$-22.29M	$-19.36M	$-3.22M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RNTX	$40.66M	19	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Rein Therapeutics Inc trades at $1.36. Our Smart Value Score of 19/100 indicates the stock is weak.

Frequently asked questions

What is Rein Therapeutics Inc's stock price?

Rein Therapeutics Inc (RNTX) trades at $1.36.

Is Rein Therapeutics Inc overvalued?

Smart Value Score 19/100 (Grade F, Strong Sell).

What is the price target of Rein Therapeutics Inc (RNTX)?

The analyst target price is $10.00, representing +638.0% upside from the current price of $1.36.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-139.90%

Beta1.40

50D MA$1.37

200D MA$1.32

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RNTX vs LLY →RNTX vs JNJ →RNTX vs ABBV →Stock screener →